APA

Stellbrink H., Reynes J., Lazzarin A., Voronin E., Pulido F., Felizarta F., Almond S., St Clair M., Flack N. & Min S. (20140110). Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study. : AIDS (London, England).

Chicago

Stellbrink Hans-Jürgen, Reynes Jacques, Lazzarin Adriano, Voronin Eugene, Pulido Federico, Felizarta Franco, Almond Steve, St Clair Marty, Flack Nancy and Min Sherene. 20140110. Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study. : AIDS (London, England).

Harvard

Stellbrink H., Reynes J., Lazzarin A., Voronin E., Pulido F., Felizarta F., Almond S., St Clair M., Flack N. and Min S. (20140110). Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study. : AIDS (London, England).

MLA

Stellbrink Hans-Jürgen, Reynes Jacques, Lazzarin Adriano, Voronin Eugene, Pulido Federico, Felizarta Franco, Almond Steve, St Clair Marty, Flack Nancy and Min Sherene. Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study. : AIDS (London, England). 20140110.